Codar GF and Moxetumomab pasudotox
Determining the interaction of Codar GF and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: codeine / guaifenesin
Brand name: Allfen CD, Cheracol with Codeine, Cheratussin AC, Codar GF, Duraganidin NR, Guaiatussin AC, Iophen-C NR, Mar-cof CG, M-Clear, Mytussin AC, Relcof C, Guaifenesin AC Liquid, Iophen C-NR, Mar-cof CG, Ninjacof-XG, Virtussin A/C
Synonyms: n.a.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Codar GF-Moxetumomab Pasudotox-tdfk
- Codar GF-Moxetumomab pasudotox-tdfk Intravenous
- Codar GF-Moxifloxacin
- Codar GF-Moxifloxacin (Systemic)
- Codar GF-Moxifloxacin Hydrochloride
- Codar GF-Moxifloxacin Injection
- Moxetumomab pasudotox-Codeine
- Moxetumomab pasudotox-Codeine and Chlorpheniramine
- Moxetumomab pasudotox-Codeine and Chlorpheniramine ER Tablets
- Moxetumomab pasudotox-Codeine and Chlorpheniramine Extended-Release Suspension
- Moxetumomab pasudotox-Codeine and Chlorpheniramine Extended-Release Tablets
- Moxetumomab pasudotox-Codeine and Chlorpheniramine Liquid